Literature DB >> 27168341

Initial Treatment of Progressive Differentiated Thyroid Cancer.

R M Tuttle1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27168341

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  1 in total

Review 1.  Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit.

Authors:  Lori J Wirth; Cosimo Durante; Duncan J Topliss; Eric Winquist; Eyal Robenshtok; Hiroyuki Iwasaki; Markus Luster; Rossella Elisei; Sophie Leboulleux; Makoto Tahara
Journal:  Oncologist       Date:  2022-07-05       Impact factor: 5.837
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.